High-frequency rTMS targeting the motor cortex has shown potential in improving motor performance and reducing spasticity by enhancing cortical excitability and promoting neuroplasticity (Hassan et al., 2021)
dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon like peptide-1 receptor agonists (GLP-1 RA) and sodiumglucose cotransporter-2 (SGLT2) inhibitors
In mammals, ferroptosis has been implicated in diverse pathologies, including neurodegenerative diseases, stroke, traumatic brain injury and kidney degeneration, as well as in carcinogenesis, where it may exert a tumor-suppressor function
However, it is banned by the World Anti-Doping Agency (WADA) for Olympic, professional, and championship-level athletes due to its performance-enhancing potential
How do oral and injectable BPC-157 differ